Steven Kelly | BiotechTV

top of page

Apr 4

Carisma Therapeutics' CEO on refocusing its pipeline this week and what the company has learned in the clinic

CEO Steven Kelly described the scientific basis of pipeline changes they have made this week and when we can expect to see data.

Carisma's CEO discusses their Moderna-partnered CAR-M preclinical late breaker at #SITC23

Nov 3, 2023

Company News

Carisma's CEO discusses their Moderna-partnered CAR-M preclinical late breaker at #SITC23

Steven Kelly describes how Carisma is leveraging Moderna's mRNA and LNP expertise to engineer monocytes in-vivo to act as a cell therapy.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Klein Hersh is a precision executive search firm with over 25 years of proven success partnering with clients to deliver the visionary leaders shaping the future of life sciences and healthcare. We believe that the innovation behind a healthier world starts with bringing the best and brightest minds together. Our experienced team of dedicated experts is deeply immersed in every facet of pharma, biotech, and healthcare, and has developed trusted relationships with far-reaching talent networks.

Visit Klein Hersh